SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-328962
Filing Date
2021-11-15
Accepted
2021-11-15 07:52:55
Documents
12
Period of Report
2021-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d263463d8k.htm   iXBRL 8-K 23288
  Complete submission text file 0001193125-21-328962.txt   141248

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20211112.xsd EX-101.SCH 2883
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20211112_lab.xml EX-101.LAB 17374
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20211112_pre.xml EX-101.PRE 10947
5 EXTRACTED XBRL INSTANCE DOCUMENT d263463d8k_htm.xml XML 3233
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 211406396
SIC: 2836 Biological Products, (No Diagnostic Substances)